Real-World Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Therapy in Nondiabetic Autosomal-Dominant Polycystic Kidney Disease: Effects on Progression to Dialysis in a TrinetX Cohort
{{output}}
Objective: To investigate the association between sodium-glucose cotransporter-2 inhibitor (SGLT2i) use and the risk of progression to chronic dialysis in nondiabetic adults with autosomal-dominant polycystic kidney disease (ADPK... ...
